
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Neurotech International Limited is a medical devices business based in Australia. Neurotech International shares (NTI) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Neurotech International has a trailing 12-month revenue of around $80,341..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
Since the stock market crash in March caused by coronavirus, Neurotech International 's share price has had significant positive movement.
Its last market close was $0.026, which is 73.08% up on its pre-crash value of $0.007 and 766.67% up on the lowest point reached during the March crash when the shares fell as low as $0.003.
If you had bought $1,000 worth of Neurotech International shares at the start of February 2020, those shares would have been worth $444.44 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,888.89.
52-week range | $0.003 - $0.024 |
---|---|
50-day moving average | $0.0146 |
200-day moving average | $0.0108 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.041 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.026 on 2020-10-22
1 week (2021-01-12) | -42.22% |
---|---|
1 month (2020-12-18) | -50.00% |
3 months (2020-10-19) | 30.00% |
6 months (2020-07-17) | 188.89% |
1 year (2020-01-17) | 73.33% |
---|---|
2 years (2019-01-15) | N/A |
3 years (2018-01-19) | -84.76% |
5 years (2016-01-15) | N/A |
Revenue TTM | $80,341 |
---|---|
Gross profit TTM | $25,447 |
Return on assets TTM | -220.08% |
Return on equity TTM | -346.14% |
Profit margin | 0% |
Book value | 0.002 |
Market capitalisation | $8.5 million |
TTM: trailing 12 months
We're not expecting Neurotech International to pay a dividend over the next 12 months.
Over the last 12 months, Neurotech International 's shares have ranged in value from as little as $0.003 up to $0.024. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Neurotech International 's is 3.6408. This would suggest that Neurotech International 's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism, a portable electroencephalographic medical device that uses neuro feedback to relax the minds of children with autism spectrum disorder. The company focuses on developing neuro-stimulation and neuro-diagnostic solutions that enable medical practitioners to monitor and play an active role in home-based therapies. It also engages in executing of medical research projects; and developing of technological devices and other solutions for the screening and treatment of neurological disorders. The company was incorporated in 2016 and is based in Nedlands, Australia.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.